WithdrawnNCT01453465

Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor

Studying Atypical teratoid rhabdoid tumor

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Oncology Group
Principal Investigator
Simone Sredni
Children's Oncology Group
Intervention
Laboratory Biomarker Analysis(other)
Eligibility
All sexes
Timeline
2011

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01453465 on ClinicalTrials.gov

Other trials for Atypical teratoid rhabdoid tumor

Additional recruiting or active studies for the same condition.

See all trials for Atypical teratoid rhabdoid tumor →

← Back to all trials